US$ 29.58
glp-1 agonists uses - What is it? GLP-1 Medications: Everything You Need
Description
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

R., & Su, S

Gastric Sleeve vs GLP-1: The Long-Term Results Matter More Than the Early Hype When people compare GLP-1 medications and gastric sleeve, they often compare the first several months

Retatrutide, an investigational triple GIP/GLP-1/glucagon receptor agonist developed by Eli Lilly, demonstrated unprecedented weight loss in Phase 2 trials but has not yet completed Phase 3 development

Sawami K, Tanaka A, Node K (2022) Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists